| DC Field | Value | Language |
|---|
| dc.contributor.author | Severina, H. I. | - |
| dc.contributor.author | Georgiyants, V. A. | - |
| dc.contributor.author | Kovalenko, S. M. | - |
| dc.contributor.author | Avdeeva, N. V. | - |
| dc.contributor.author | Yarcev, A. I. | - |
| dc.date.accessioned | 2022-05-04T09:23:54Z | - |
| dc.date.available | 2022-05-04T09:23:54Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | Molecular docking studies of N-substituted 4-methoxy-6-oxo-1-aryl-pyridazine-3-carboxamide derivatives as potential modulators of glutamate receptors / H.I. Severina [et al.] // Research Results in Pharmacology. - 2020. - Vol.6, №1.-P. 69-82. - Doi: 10.3897/rrpharmacology.6.52026. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46565 | - |
| dc.description.abstract | In the present study, the affinity of pyridazine derivatives for the most promising antiparkinsonian biotargets - I-III groups of metabotropic and ionotropic NMDA-glutamate receptors - was evaluated | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | pyridazine | ru |
| dc.subject | antiparkinson agents | ru |
| dc.subject | docking | ru |
| dc.subject | mGluR | ru |
| dc.subject | NMDA | ru |
| dc.title | Molecular docking studies of N-substituted 4-methoxy-6-oxo-1-aryl-pyridazine-3-carboxamide derivatives as potential modulators of glutamate receptors | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 6, № 1
|
